Check-Cap Issues Letter To Shareholders (Full Letter)
Check-Cap Issues Letter To Shareholders (Full Letter)
Checkcap 向股东发出信函（完整信函）
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ:CHEK), (NASDAQ:CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today issued the following letter from its chief executive officer, Alex Ovadia, to its shareholders and the investment community:
Check-Cap Ltd.(以下简称“公司”或“Check-Cap”)(纳斯达克代码：CHEK)，一家推进C-®开发的临床阶段医疗诊断公司(纳斯达克代码：CHEKZ)，这是第一种也是唯一一种对患者友好的免准备筛查测试，可以在息肉转化为结直肠癌之前发现它们。该公司首席执行官亚历克斯·奥瓦迪亚今天发表了以下致股东和投资界的信：
Dear Check-Cap Shareholders,
尊敬的Check-Cap股东们，
We have greatly appreciated your support throughout 2021, a year during which we have continued our progress as we prepare to initiate our U.S. pivotal study of C-Scan, including strengthening our...
我们非常感谢您在2021年期间对我们的支持，在这一年里，我们继续...
登录免费看全文
登录/注册